For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for ICICI Bank Ltd. (IBN) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-09-11): Designation Watch · Gem Score +15 (−100…+100 Quality+Value blend) · Quality 73 · Value -24 · Sentiment -15 (timing only, not weighted) · Composite fair value $157.24 vs $30.58 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
ICICI Bank Ltd.
IBN NYSEICICI Bank Ltd. Sponsored ADR is an American depositary receipt representing shares of ICICI Bank, one of India’s leading private-sector banks. It provides U.S. investors with access to the bank’s core banking franchise through a U.S.-traded security, while the underlying business serves retail, corporate, and institutional clients across India and select international markets. ICICI Bank offers a broad range of financial services, including savings and current accounts, loans, credit cards, payment solutions, trade finance, treasury operations, and wealth management. The bank also supports digital banking and transaction services for individuals, small businesses, and large enterprises. As a diversified financial institution, ICICI Bank Ltd. Sponsored ADR reflects exposure to the Indian banking and financial services sector through a depositary receipt structure rather than a direct local shareholding arrangement.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.56
Total Equity: $38.52B
Shares: 3,624,963,187
Total Debt: $22.03B
Cash: $30.79B
EBITDA: N/A
Total Debt: $22.03B
Cash: $30.79B
Revenue: $23.38B
Revenue: $23.38B
Revenue: $23.38B
Total Equity: $38.52B
Tax Rate: 25.1%
Equity: $38.52B
Total Debt: $22.03B
Cash: $30.79B
Current Liabilities: N/A
Long-Term Debt: $19.42B
Total Debt: $22.03B
Total Equity: $38.52B
Shares: 3,624,963,187
Shares: 3,624,963,187
CapEx: $0.00
Shares: 3,624,963,187
Stock Price: $30.58
Net Income: $5.67B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 28, 2026 9:53am (23d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $12.2B | $14.0B | $16.9B | $19.1B | $23.4B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $2.7B | $3.2B | $3.9B | $3.4B | $6.8B |
| Operating Income | — | — | — | — | — |
| Net Income | $2.6B | $3.6B | $4.6B | $5.3B | $5.7B |
| EBITDA | — | — | — | — | — |
| EPS | $0.76 | $1.02 | $1.32 | $1.52 | $1.59 |
| EPS (Diluted) | $0.74 | $1.00 | $1.30 | $1.49 | $1.56 |
Balance Sheet (Annual)
Last updated: Sep 2, 2026 11:30pm (18d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $22.7B | $17.4B | $20.2B | $25.3B | $30.8B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | — | — | $250.8B | $280.3B | $309.2B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | $15.9B | $18.4B | $19.5B | $19.2B | $19.4B |
| Total Liabilities | — | — | $222.2B | $245.4B | $268.9B |
| Total Equity | $19.3B | $22.8B | $27.2B | $33.3B | $38.5B |
| Retained Earnings | — | — | — | $12.6B | $15.7B |
Cash Flow (Annual)
Last updated: Sep 2, 2026 11:30pm (18d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $20.8B | $17.9B | $36.8B | $32.4B | $7.1B |
| Capital Expenditure | -$184.9M | -$231.3M | -$382.8M | -$499.2M | — |
| Free Cash Flow | $6.0B | -$661.9M | $16.3B | $12.5B | $6.7B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | $1.9B | $2.9B | $1.9B | $1.2B | $194.4M |
| Dividends Paid | -$147.0M | -$369.1M | -$594.0M | -$747.0M | -$833.1M |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | $3.8B | -$5.0B | $2.8B | $5.4B | $5.4B |
Growth Trends (YoY %)
Last updated: Aug 28, 2026 9:53am (23d ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue Growth | +15.3% | +20.1% | +13.0% | +22.6% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | +35.5% | +30.0% | +15.3% | +6.2% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Sep 2, 2026 11:30pm (18d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-03 | $0.25 | — | — | — |
| 2025-08-12 | $0.26 | — | — | — |
| 2024-08-12 | $0.24 | — | — | — |
| 2023-08-08 | $0.19 | — | — | — |
| 2022-08-09 | $0.13 | — | — | — |
| 2021-07-28 | $0.05 | — | — | — |
| 2019-07-23 | $0.03 | — | — | — |
| 2017-06-19 | $0.07 | — | — | — |
| 2016-06-14 | $0.14 | — | — | — |
| 2015-06-03 | $0.14 | — | — | — |
| 2014-07-01 | $0.14 | — | — | — |
| 2013-05-29 | $0.12 | — | — | — |
| 2012-05-30 | $0.10 | — | — | — |
| 2011-06-01 | $0.11 | — | — | — |
| 2010-06-09 | $0.09 | — | — | — |
| 2009-06-10 | $0.08 | — | — | — |
| 2008-07-09 | $0.09 | — | — | — |
| 2007-06-13 | $0.09 | — | — | — |
| 2006-07-06 | $0.07 | — | — | — |
| 2005-08-03 | $0.06 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-09-07 02:01Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-09-03 00:10The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The synthesis output claiming a "$218.69 fair value → signal-adjusted $295.95" against a $30.58 ADR price is a garbage-in artifact and should be discarded outright. This is a US-listed ADR representing two underlying INR-denominated shares; the DCF machinery is almost certainly comparing INR-scaled financials (revenue $23.4B, NI $5.67B, equity $38.5B — all correctly USD-converted) against a per-share value that got tangled in the 2:1 ADR ratio and rupee-to-dollar conversions. The stock trades at ~19.5x earnings and 2.88x book, which is a **premium** to global bank peers, not a 90% discount. Any model spitting out $295 fair value on a $30 bank ADR without flagging the ADR/FX mechanics has failed a basic sanity check, and the "Market Narrative" layer's claim of "0.3x book in USD terms" is nonsense — the P/B is 2.88x per the canonical metrics on the same page.
Working from the actual numbers: ICICI has compounded revenue at 17.7% and earnings at 10.7% over five years (rev $12.2B → $23.4B; NI $2.63B → $5.67B). That's a genuinely excellent trajectory for a bank of this scale, ROE 14.7%, ROA 1.83% — both healthy for an EM bank. But earnings growth has decelerated: recent YoY earnings +6.2% against revenue +22.6% means net margin compressed from ~28% to 24.3%. That's the "margin compression" the bear case flags, and it's real, though the bull explanation (mix shift into higher-cost deposits and tech investment during a rate-cycle turn) is plausible for Indian private banks right now. The alleged "-55.7% FCF CAGR" and "catastrophic cash flow deterioration" bear point is analytically meaningless for a bank — operating cash flow for lenders swings wildly with loan book growth and deposit flows; it is not a quality signal the way it is for industrials. The Thesis Evaluator weighting that at 85/100 is a category error.
The contrarian case that actually has teeth is different from what the models surfaced. First, Indian private-bank valuations at 2.9x book and 19.5x earnings already price in the financialization story — HDFC, Kotak, Axis all trade in similar bands, and this is not a hidden gem. Second, credit costs in India are near cycle lows; unsecured retail (personal loans, credit cards) has been the growth engine and the RBI has been explicitly warning about it since late 2023, raising risk weights. When that cycle turns, ROE compresses fast. Third, for a US-based holder, the rupee has depreciated roughly 3-4% annually against USD structurally, which mechanically erodes returns — the ADR at $30.58 embeds that drag, not a discount. Fourth, insider activity isn't provided here, which for a bank of this scale and ownership structure isn't meaningful anyway.
Where I land: the "mature_earner" classification is correct, the "quiet-quality / anchored narrative" read is correct, and the "Neutral Market Forces" caution about late-cycle lending is directionally right. The synthesis verdict of massive undervaluation is broken math. The Thesis Evaluator's -12 score is closer to reality but is arrived at via the wrong bear argument (bank FCF). Fair value for IBN at 15% sustainable ROE, ~10-11% forward earnings growth, and Indian rate/FX headwinds is roughly 2.5-3.0x book and 17-19x earnings — i.e., approximately where it trades. This is a fairly-valued high-quality EM bank, not a screaming buy and not a short. A US holder gets India banking exposure with a persistent FX drag; that's the trade, priced accordingly. I'd only get interested below ~$26 (roughly 2.4x book, 16x earnings) or on a rupee stabilization catalyst. I'd trim above ~$35 unless earnings growth reaccelerates back above 12%.
GPT Reading
What jumps out is that the valuation-synthesis output is obviously unusable on its face. A supposed fair value of $218 to $296 versus a $30.58 ADR price is almost certainly a unit/ADR-ratio or currency translation error, and treating that as economic upside would be a category mistake. On the underlying business, though, the numbers are still strong. Revenue rose from $12.18B in FY2022 to $23.38B in FY2026, a 17.7% CAGR, while net income increased from $2.63B to $5.67B. That is not just top-line inflation: ROE is 14.7%, ROA 1.83%, and the bank is generating $7.14B of operating cash flow and $6.75B of free cash flow against a $109.7B market cap. The balance sheet snapshot is also cleaner than many banks screened naively through generic datasets: cash of $30.79B exceeds total debt of $22.03B, and equity stands at $38.52B. For a large private-sector Indian bank, 2.88x book and 19.5x earnings are premium multiples, but they are not irrational if you believe mid-teens compounding can persist.
The core story in the raw numbers is that ICICI has already done the hard part of rehabilitation and is now being valued as a quality compounder, not a turnaround. Net income margin has held at 24.3% on the latest annual figures, and earnings have compounded more slowly than revenue over the last four years, 10.7% versus 17.7%, which tells you some combination of mix normalization, competitive pricing, and balance-sheet growth is diluting incremental profitability. But even with that, profits still climbed every year: $3.56B, $4.63B, $5.34B, $5.67B from FY2023 through FY2026. The deceleration matters: latest revenue growth of 22.6% versus earnings growth of just 6.2% is a yellow flag, because a bank that grows assets and revenue much faster than profits is often either giving up margin or carrying higher provisioning/operating costs. That, more than any heroic DCF, is where the real debate sits.
I come out at roughly fairly valued to modestly expensive here, not because the franchise is weak but because the current multiple already assumes continued execution. At 2.88x book, the market is paying a hefty premium for a 14.7% ROE bank. That can work in India if investors are underwriting a path to sustainably higher ROE, long runway loan growth, and benign credit costs, but the present data do not prove an inflection upward in profitability. In fact, the recent growth split points the other way. A mature bank compounding earnings at 6%-11% does not deserve to be discussed as if it were deeply mispriced just because the ADR trades at a low nominal dollar price. With a payout ratio of 14.7%, management is retaining capital for growth, which is sensible, but it also means the investment case is overwhelmingly dependent on reinvestment earning superior returns. Right now, the returns are good, not obviously underappreciated.
The best case against my caution is straightforward: this is exactly the kind of bank that often looks “expensive” all the way through a long compounding cycle. If ICICI can keep revenue growth above 15%-20%, defend ROE around 15% or lift it, and avoid credit deterioration, then 19.5x earnings may prove entirely reasonable for a dominant private bank in an underbanked economy. The low debt-to-equity ratio of 0.57 in the dataset, positive free cash flow, and steady annual earnings progression all argue that the “hidden stress” language from one of the prior model outputs is overreaching. I also weigh the cash-flow-based bear arguments lightly because bank cash flow statements are notoriously poor tools for judging economic health; balance-sheet movements swamp the signal, and generic FCF metrics are often less meaningful for banks than earnings, capital adequacy, deposit mix, and credit costs. So the smarter bull case is not “the model says 800% upside,” it is “this is a scarce, high-quality Indian banking franchise and premium assets stay premium.”
What would change my mind is evidence that the recent earnings deceleration is temporary rather than structural. If the next annual period shows net income reaccelerating back toward the revenue trajectory — say profit growth back into the mid-teens with ROE above 15% and book value compounding strongly enough to make 2.9x book look less demanding — I would get more constructive even at a higher price. Conversely, if revenue keeps growing above 20% while earnings stay near mid-single digits, or ROE slips below roughly 14% without a clear investment-phase explanation, then this multiple is too full and I would turn outright negative. For now, I see a genuinely good bank priced like a genuinely good bank, with little room for slippage and no basis for the absurd fair-value outputs embedded in the models.
Grok Reading
The numbers on ICICI tell a story of a high-quality franchise whose top line is still compounding hard while the earnings engine is clearly downshifting. Revenue has marched from $12.18B in FY2022 to $23.38B in FY2026—a 17.7% CAGR—with the latest year still accelerating at 22.6% year-over-year. Net income, however, only rose from $5.34B to $5.67B, a 6.2% increment that is a sharp break from the prior multi-year earnings CAGR near 11%. The 24.3% net margin remains elite for a bank, ROE sits at a respectable 14.7%, and the balance sheet is clean: $30.8B cash against $22.0B debt, equity of $38.5B, and a modest 0.57 debt-to-equity. Operating cash flow of $7.14B and free cash flow of $6.75B in the latest year look healthy in absolute terms. At $30.58 the stock trades at 19.5x earnings and 2.88x book—multiples that already embed continued mid-teens ROE and India’s financialization runway. What stands out is the divergence: revenue and market-share gains are being bought with visible margin compression, and the market is still awarding a premium multiple as if the old earnings trajectory remains intact.
The prior quantitative layer is internally incoherent and should be discarded where it conflicts with the raw series. The valuation synthesis spits out a “fair value” near $219–$296 and nearly 900% upside; that is an obvious unit or share-count error (likely INR/USD or diluted-share mishandling) and cannot be taken seriously against a $110B market cap and 19.5x trailing earnings. Likewise the –55.7% FCF CAGR collides with both the latest $6.75B FCF print and the secondary “strong cash-flow quality” flag; bank FCF is volatile by nature when the loan book is expanding, so the catastrophic-cash-flow bear case is overstated relative to the income-statement and capital ratios. The more credible tension is the one the market-forces and thesis layers correctly flag: aggressive late-cycle lending is supporting the 22% revenue print while earnings growth has collapsed to mid-single digits. A 19.5x multiple on 6% earnings growth is not a bargain; it is a valuation that requires the margin squeeze to reverse.
The strongest case against this read is that India’s private-bank compounders have historically deserved—and re-rated on—precisely this combination of deposit franchise, digital scale, and multi-decade credit-penetration runway. Bulls will correctly note that ROE of 14.7%, a 15% payout, net cash, and 18% revenue CAGR still look superior to most global regional banks, that the P/B of 2.9x is consistent with a mid-teens ROE grower in a high-nominal-GDP market, and that temporary mix-shift and investment spend can explain the earnings lag without implying hidden NPAs. They will also argue the ADR trades at a structural discount to local-currency value, so the “true” multiple is lower than the USD screen suggests. I weigh that less heavily because the deceleration is already multi-year in the earnings CAGR, the latest year shows the gap widest (22% sales vs 6% profit), and there is no forensic evidence in the briefing that asset quality is pristine enough to underwrite a re-acceleration back to mid-teens EPS growth. Paying 19.5x for hope that margins normalize is the risk, not the base case.
I would flip to a clear undervalued stance if the next two semi-annual prints show net-interest margin stabilization and earnings growth re-accelerating above 12–14% while NPL formation stays benign; conversely, another year of sub-8% earnings growth or a step-up in credit costs would make the current multiple look expensive and push me firmly overvalued below the mid-$20s.
Qwen Reading local experiment · off-panel
The number that should stop you cold in this dataset is the divergence between the 22.6% revenue growth in FY26 and the 6.2% net income growth in the same year. ICICI's revenue jumped from $19.10B to $23.42B — a $4.3B increase — yet net income only crept from $5.35B to $5.68B, a $330M gain. Net margin compressed from roughly 28% to 24.3% in a single fiscal year, after having *expanded* from 21.6% to 28.0% over the prior three years. That is not a rounding error; that is the margin engine stalling. For a bank, this almost always means one of three things: a provisioning spike ahead of a credit cycle turn, net interest margin compression from a rate environment shift, or a one-off charge (restructuring, regulatory penalty, goodwill write-down). The data briefing doesn't tell you which, and that ambiguity is the entire investment question. At 19.07x trailing earnings and 2.85x book with a 14.9% ROE, the market is paying a developed-market-quality multiple for an emerging-market bank, and that multiple is only defensible if the 28% margin era is the base case, not the 24.3% one.
I want to be blunt about two of the prior model outputs because they are, in my view, simply wrong. The "Valuation Synthesis" model declares a fair value of $220.66, implying a 749% upside from $29.89. That is a unit error — almost certainly a mix-up between INR-denominated per-share values and the ADR price, or a misapplied DCF terminal value. No bank with a 14.9% ROE and 19x P/E is 750% undervalued; that would imply a P/E above 150x. I am discarding that number entirely. Equally, the "Market Forces" model flags a "-55.7% FCF CAGR" and a "6.83x accrual ratio" as a "classic growth-at-any-cost red flag." This is a category error. ICICI is a bank. It does not have capex in the industrial sense (the data literally shows "Capex: —"), its "operating cash flow" of $7.06B is driven by loan book rotation and deposit flows, and "free cash flow" is a meaningless construct for a depository institution. The FCF CAGR metric is an artifact of applying an industrial-equity screen to a balance-sheet business. I give it zero weight.
What the data actually supports is a more measured picture. Five years of revenue from $12.20B to $23.42B is a 17.7% CAGR, and the 10.7% earnings CAGR over the same window is respectable for a bank operating in a 6-7% GDP-growth economy with rising financial penetration. The balance sheet is clean by banking standards: $30.42B in cash and equivalents against $21.76B in total debt (which for a bank is overwhelmingly customer deposits, not funded borrowings), and $38.06B in equity. The 14.5% payout ratio tells you management is reinvesting 85.5% of earnings into the loan book, which is the correct posture for a bank still gaining market share in India. Insider activity is a wash — the two 45,000-share sales in late April are dwarfed by the option exercises and the 125,600-share award in the same window, and the net flow is modestly positive. The "quiet-quality" narrative classification is accurate: this is not a stock being bid on a story; it is a stock being carried on fundamentals with a structural ADR liquidity discount layered on top.
The strongest case against my read is the margin compression itself, and I will not wave it away. A smart bear would point to the FY26 numbers and say: "You are paying 19x for a bank whose earnings growth just decelerated to 6.2% while revenue growth is still 22.6%. That gap is provisioning. Indian private banks are entering a credit cycle where the 2022-2024 NPA trough is rolling over, and ICICI's 14.9% ROE is about to become 11% or 12% as provisions normalize. At 19x, you are paying for the 28% margin year, not the 24% one." That is a legitimate concern, and the 6.2% earnings print is the single most important data point in this entire briefing. I weigh it differently from a pure bear because the five-year trend shows margin *expansion* through FY25, which suggests the FY26 compression is more likely a one-off provisioning event or a rate-cycle NIM dip than a structural break. But I acknowledge I cannot confirm that from this dataset alone, and if the next two quarters show continued margin erosion, the 19x multiple becomes expensive.
What would flip my verdict: I need to see the NIM trajectory and the gross NPA / SLA ratio in the next two quarterly prints. If NIM stabilizes above 4.0% and gross NPAs stay below 1.5%, the FY26 margin dip was a one-off and the 19x P/E is fair-to-slightly-cheap for a 17.7% revenue grower with a 14.9% ROE, and I would lean undervalued. If NIM compresses below 3.5% or NPAs tick above 2.0%, the earnings CAGR is about to fall below 8% and the stock is overvalued at 19x. I also need to see whether the $23.42B revenue figure includes any one-off items (trading gains, fee spikes) that would make the 22.6% growth rate less organic than it appears. Until I see those numbers, I am holding at fairly valued with a modest bull lean.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has compounded from $12.2B (2022) to $23.4B (2026), while net income nearly doubled from $2.63B to $5.67B over the same span — a clean, monotonic march with no down years. Operating cash generation is heavy: $6.75B FCF in the latest year on top of $12.5B and $16.3B in the two prior years, reflecting deposit-funded balance sheet growth typical of a scaled bank. Liquid cash of $30.8B against a net cash position of $8.8B indicates ample liquidity, though for a bank these figures reflect regulatory reserves and interbank positioning rather than corporate 'dry powder.' Dilution is essentially absent — diluted shares crept from 3.54B to 3.62B (0.6% CAGR) and SBC is 0.4% of revenue, so per-share earnings track headline earnings faithfully. Accruals at -7.7% of assets and OCF/NI of 5.64x look pristine on the surface, though these ratios are noisy for banks where 'operating cash flow' is dominated by deposit inflows and loan book movements rather than earnings quality per se. The Altman Z of 0.39 flagging 'distress' is a false positive — Z-scores are calibrated to industrials and routinely misclassify banks, whose leverage is structural. Classification as a mature_earner fits: this is a scaled, profitable franchise growing net income mid-teens with stable share count.
Verify before trusting this (6)
- Gross NPL and net NPL ratios and provisioning coverage trend over 3-5 years
- Unsecured retail loan mix and growth rate (personal loans, credit cards) given RBI risk-weight changes
- CET1 and total capital adequacy ratio versus regulatory minimums
- CASA deposit ratio and cost of funds trajectory
- Any related-party lending or promoter/group exposures
- Segment breakdown: retail vs corporate vs treasury contribution to earnings
The e2e composite fair value of $218.69 and signal-adjusted $295.95 imply ~868% upside, which fails a basic sanity check — no liquid, well-covered $110bn ADR trades at a tenth of deserved value. The DCF at $311 is a runaway output (likely extrapolating Indian growth in local terms without a rupee/ADR discount and ignoring bank capital intensity). The anchored-PE mark of $33.83 is the credible anchor here, implying roughly 10% upside to fair. That is a fairly-valued read, not a discount. Against a Strong quality grade (73) and clean earnings, ICICI deserves a premium multiple among EM banks, and the market appears to be giving it exactly that. The bear points — rupee drag, ADR frictions, EM-bank multiple compression — are legitimate deserved-value haircuts that keep the anchored-PE number honest. Net: price roughly matches deserved value; margin of safety is thin. I would need a clear pullback to open a real gap.
Verify before trusting this (5)
- Latest GNPA/NNPA and credit cost trajectory vs guidance
- Net interest margin trend as RBI rate path evolves
- Segment mix shift (retail vs corporate) and unsecured retail growth
- Any RBI regulatory actions on unsecured lending or provisioning
- Book value per ADR and ROE trend in USD terms after FX
IBN sits in a sentiment vacuum. The narrative is minimal-intensity 'quiet-quality' with low cult coefficient - there is no active story pulling money in or a broken thesis pushing it out. Recent news is entirely ambient: generic 'Asian ADRs up/down' tape prints and a product feature note. Nothing on the wires is stock-specific enough to move sentiment either way. The tape is a mildly constructive Neutral (+19) with VIX at a benign 15.2, and IBN's 0.26 beta means even a sharper risk-off swing would barely register mechanically. With a strong-positive momentum score (17.7% CAGR), there's a passive tailwind from trend-followers and index flows, but nothing narrative-driven. The macro overlay is the real, if quiet, headwind: 10y at 4.79% and market PE 25.8 keep EM-financial ADRs from getting a valuation re-rate, and structural rupee weakness plus ADR custody drag are exactly the kind of persistent, low-intensity press that keeps USD holders from bidding it up. That's a genuine but ordinary crosswind, not a decisive force. Net: forces roughly cancel - a mild trend tailwind and calm tape offset by low-grade EM-ADR/FX headwind and the absence of any bullish narrative to catalyze re-rating.
Verify before trusting this (4)
- Any INR/USD move that changes the ADR arbitrage or an RBI policy shift
- Whether Indian bank sector sentiment turns (credit cycle worries or index inflow catalysts)
- Analyst target revisions or a fresh narrative angle (digital, unsecured credit) picking up intensity
- US 10y direction - a sharp drop would lift EM financial ADR sentiment
Two worlds are being conflated. The measured category is a mature, contracting Western regional-bank complex; ICICI operates in an under-penetrated credit market where household leverage, mortgage penetration and digital payments are all still climbing structurally. Macro headwinds (10y 4.79, flattish curve at 0.4) matter mainly through the rupee and foreign flows, not through Indian loan demand. The live cyclical variable is the domestic rate cycle: policy cuts squeezed asset yields ahead of deposit costs, which is exactly what the 22.6% revenue / 6.2% earnings split shows. As deposits reprice, that scissor closes. The structural variable is credit cost normalisation in unsecured retail. Neither threatens the volume engine; both modulate the earnings conversion. The house's +20.7% projection is plausible on revenue but likely optimistic on near-term earnings; the price-implied -10% is a description of India-discount and currency fear, not of the business's direction.
When we made this prediction on Sep 3, 2026, IBN was $30.45. We expect it to be $32.10 by Mar 2027, and we consider it great value under $26.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 3, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.